2004, Number 1
<< Back Next >>
Rev Mex Patol Clin Med Lab 2004; 51 (1)
Avian influenza The first pandemic of the 21th century?
Barriga AG, Arumir EC, Mercado GF
Language: Spanish
References: 23
Page: 16-23
PDF size: 160.68 Kb.
ABSTRACT
In the last two centuries several influenza pandemics has exacted a
high death toll from human populations, the most devastating pandemic,
the so - called Spanish influenza of 1918-1919, caused deaths of 20 to
50 million people worldwide. In three occasions in the recent
past: 1997, 1999, 2003, and starting in January of this year outbreaks
of human cases of influenza with a non recombinant virus strain of
avian influenza (H5NI) of inunsual pathogenicity and mortality (75%),
transmitted directly from birds to humans has been reported in Thailand
and Vietnam with preceding and simultaneous avian influenza outbreaks
in Cambodia, China, Hong Kong, Indonesia, Japan, Laos, South Korea,
Thailand and Vietnam with devastating effects on his poultry industry.
This situation could be the origin of a new influenza pandemic in
humans. Here we review current knowledge about the ecology,
interspecies transmission, laboratory diagnosis, clinical symptoms,
prevention, treatment, and pathogenicity of avian influenza viruses and
the human health threats posed by these pathogens.
REFERENCES
Taubenberger JK. Seeking the 1918 Spanish Influenza Virus. Am Soc M News 1999; 65(7): 473-478.
Kawaoka Y, Krauss S, Webster R. Avian to human transmission of the PBI gene of influenza A viruses in The 1957 and 1968 pandemics. J Virol 1989; 63: 4603-4608.
Cockburn WC, Delos PJ, Ferreira W. Origin and progress of the 1968-1969 Hong Kong influenza epidemic. Bull WHO 1969; 41: 345-353.
Kung HC, Ken KF, Yuan CW. Influenza in 1977 recurrence of influenza virus A Subtype HINI. Bull WHO 1978; 56: 913-918.
Webster RG. Influenza virus: transmission between species and relevance to emergence of the next human pandemic. Arch Virol 1997; 142(Suppl. 13): 105-113.
CPC. Isolation of avian influenza A (H5NI) Viruses from humans - Hong Kong 1997-1998. Morb Mortal Wkly Rep 1998; 46: 1245-1247.
Guan YK, Shortridge KF, Krauss S, Li PH, Kawaoka Y, Webster RG. Molecular characterization of H9N2 influenza viruses: were they donors of the internal genes of H5NI viruses in Hong Kong. Proc Natl Acad Sci 1999; 96: 9365-9367.
World Health Organization Avian influenza frequently asked questions 20004, January http/www/who int/wer
OMS-WER February 13 2004 7, 2004; 79: 65-76
World Health Organization. Avian influenza A (H5NI) update 33: Situation (human) in Thailand 2004 March http/www/who-int/wer
MMWR. Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2003 52 RRO8 1-36.
Levine AJ. VIRUSES The influenza A Virus 1992-155–175. Scientific American Library New York 10010 USA.
Horimoto T, Kawaoka Y. Pandemic Treat Posed by Avian Influenza A Viruses. Clin Microb Rev 2001; 14: 1, 129-149.
Cox NJ, Subbarao K. Global epidemiology on influenza: past and present. Annu Rev Med 2000; 51: 407-421.
Dowell SF. Seasonal Variation in Host Susceptibility and cydes of Certain Infectious Diseases. Emerg Infect Dis 2001; 7(3): 369-371.
Manto AS, Koopman J, Longini IM. Tecomseh study of illness XIII. Influenza infection and disease. Am J Epidemiol 1985; 121: 811-822.
WHO. Preliminary clinical and epidemiological description on influenza A (H5NI) in Viet Nam. 2004; 7(79): 65-76.
Layne SP, Beugelgdij KTJ, Patel CK, Taubenberger JK, Cox NJ, Gust ID. A global lab against influenza. Science 2001: 293: 1729.
Peiris M, Yam WC, Chan KH, Ghose P, Shortridge KF. Influenza a. H9N2: aspects of laboratory diagnosis. J Clin Microbiol 1999: 37: 3426-3427.
Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenza related lower respiratory tract Complications and hospitalizations. Arch Intern Med 2003: 163: 1667-1672.
CDCs Travelers Health page: http www cdc. Gov/travel.
Bradley SI. Prevention on influenza in long-term care facilities Infect Control Hosp Epidemiol 199; 20: 629.